PATENT CLAIM ANALYSIS

Application Number: 16507437
Application Type: Utility
Filing Date: 2019-07
Publication Date: 2019-10
Patent Classification: ["424", "093710"]

Abstract:
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 11 novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.

Claim (Index 5):
The method of  claim 1 , wherein the population of activated T cells are administered in the form of a composition.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 100.0
- Lexical Diversity: 1.57353
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16196402', '16196440', '12180170', '15357838', '15226206']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7885873280676182
- 35 USC 102 Novelty (BERT): 0.5828230975285702
- Combined Prediction Score: 0.7680109050137134
- Mean Citation Score: 410.840406
- Max Citation Score: 476.50076
- Similarity Product: 455.9665312891436

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test